Metabolic Disorders Linked to Chronic Pain in Colorectal Cancer Patients

Strategic Insights -

Researchers at the First Affiliated Hospital of Xinxiang Medical University in Henan, People's Republic of China, have conducted a study to investigate the impact of glucose and lipid metabolic disorders on the risk of chronic postoperative pain syndrome after colorectal cancer surgery. The study involved 513 patients, who were divided into two groups: one with chronic pain and the other without. The researchers found that patients with metabolic disorders were more likely to experience chronic pain, and that the risk of chronic pain was associated with elevated levels of inflammatory markers, such as IL-1b, IL-6, and TNF-a.

Key Takeaways:

  • The study found that glucose and lipid metabolic disorders were significantly associated with elevated peripheral inflammation at baseline.
  • Patients with metabolic disorders were more likely to experience chronic pain, with a odds ratio of 2.54 (95% CI: 1.43-4.53) for glucose metabolic disorders and 3.21 (95% CI: 1.83-5.60) for lipid metabolic disorders.
  • The study also found that patients with metabolic disorders experienced higher levels of depression, anxiety, and lower quality of life scores compared to those without metabolic disorders.
  • The researchers concluded that improving pathophysiological abnormalities and reducing the risk of chronic postoperative pain syndrome may contribute to health maintenance in patients after colorectal cancer surgery.
  • The study's findings have implications for the prevention and treatment of chronic pain in colorectal cancer patients, and highlight the importance of addressing metabolic disorders as a potential risk factor.

Statistics:

  • 513 patients were involved in the study, with 352 without chronic pain syndrome at baseline.
  • 161 patients with chronic pain syndrome at baseline were compared to 352 patients without chronic pain syndrome.
  • The study found that the odds ratio of chronic pain syndrome at baseline was 2.88 (95% CI: 1.73-4.78) for glucose metabolic disorders and 3.65 (95% CI: 2.21-6.03) for lipid metabolic disorders.
  • The study also found that the risk of chronic pain syndrome increased with the duration of follow-up, with an odds ratio of 1.21 (95% CI: 1.04-1.41) for each month of follow-up.

Sources:

  • Frontiers in Oncology: Impact of glucose and lipid metabolic disorders on the risk of chronic post-operative pain syndrome after colorectal cancer surgery.
  • Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland.